Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma

3M ago

GRCL

PremiumMarket News

M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B

4M ago

AZN

BMY

PremiumMarket News

M & A News: AstraZeneca (NASDAQ:AZN) to Acquire Gracell for $1.2B

4M ago

AZN

GRCL

PremiumPress Releases

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

4M ago

GRCL

$Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus$

PremiumPress Releases

Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus

4M ago

GRCL

More GRCL News >

GRCL News on the Web

2024-02-20

Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement

Yahoo Finance

Bullish

2024-02-07

Q3 2023 Gracell Biotechnologies Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-02-07

Gracell Biotechnologies Inc at Citi BioPharma Conference Transcript

GuruFocus News

Neutral

2024-02-07

Gracell Biotechnologies Inc Key Opinion Leader Webinar on Multiple Myeloma Transcript

GuruFocus News

Neutral

2024-02-07

Gracell Biotechnologies Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

GuruFocus News

Neutral

2024-02-07

Q1 2023 Gracell Biotechnologies Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-02-07

Q4 2022 Gracell Biotechnologies Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-02-07

Gracell Biotechnologies Inc at Citi Virtual Oncology Leadership Summit Transcript

GuruFocus News

Neutral

News Score - Last 7 Days

Neutral

GRCL

Sector Average

Media Buzz

This Week1 articles

Weekly Average5.75 articles

News Sentiment

This Week100%

Sector Average63%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GRCL’s Media Buzz Sentiment?

1 articles about GRCL were published this week. In an average week, 5.75 articles are published.

What is GRCL’s weekly average amount of articles?

In an average week, 5.75 articles about GRCL are published.

What is GRCL’s News Sentiment?

100% of articles about GRCL were positive this week, compared to its sector average of 63%.

Healthcare Stocks that are Trending in the News

PENPenumbra

ATNMActinium Pharmaceuticals

OMIOwens & Minor

NEONeoGenomics

EVHEvolent Health

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing